Highlights from AHS 2022 include use of ubrogepant plus onabotulinumtoxinA for breakthrough migraines, eptinezumab for migraine prevention, and vagal nerve stimulation to treat visual snow.
Food allergy and obesity raise COVID-19 infection risk, but asthma does not, according to an NIH-funded study.
Although most people with COVID-19 recover within weeks of infection, some experience long-haul conditions 4 or more weeks after infection. Does the gut hold the key to susceptibility?
To answer the many questions regarding the roll out, risk and benefits, and timing of COVID-19 vaccine administration in children aged 5 to 11 years, The Clinical Advisor interviewed Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP, a pediatric nurse practitioner and owner of Pediatric Nurse Practitioner House Calls.